Articles on HIV treatment

Displaying all articles

Philanthropist Bill Gates addresses delegates at the 2016 Aids Conference in Durban. Masimba Sasa

November 30, 2016

Leading African academics quiz Bill Gates on HIV/AIDS and the role of philanthropy

Bill Gates, Addis Ababa University

Bill Gates, who has been identified as the world's most significant donor in the fight against AIDS, shares his thoughts on the pandemic with Africa's most prominent HIV/AIDS academics.

A client receives HIV/AIDS counseling at a women and children’s hospital in Nigeria. These facilities are not always available in rural areas. Flickr/ Karen Kasmauski/MCSP

November 28, 2016

Nigeria wants to decentralise HIV treatment. But it’s proving difficult

Chinyere Mbachu, University of Nigeria and Obinna Onwujekwe, University of Nigeria

Effectively decentralising HIV and AIDS treatment services helps to improve universal health care. But in Nigeria this approach comes with many challenges.

Young women who attended the International AIDS Conference in Durban, South Africa. International AIDS Society/Rogan Ward

July 22, 2016

AIDS conference 2016: the gains, the gaps, the next global steps

Linda-Gail Bekker, University of Cape Town

The focus of the 2016 International AIDS Conference has on access to necessary antiretrovirals, equity and making sure no-one is left behind. But there is a funding gap that needs to be addressed.

South African HIV rights group, the Treatment Action Campaign, marching through Durban, calling for antiretroviral access for all. International AIDS Society/Rogan Ward

July 19, 2016

It will take more than $36 billion every year to end AIDS

Charles Shey Wiysonge, Stellenbosch University

Current epidemiological and financial trends suggest there's a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.

Anglo American’s plans to reduce its operations will have an impact on the provision of health services to miners. Reuters/Siphiwe Sibeko

February 8, 2016

Southern Africa’s retrenched miners face a future without health care

Liesl Page-Shipp, Aurum Institute

The closure of several mines in South Africa and production cuts could have a detrimental impact on the health of miners who rely on in-house HIV and TB treatment programmes.

HIV services are not geared towards men even though they make up two-thirds of the HIV-related deaths globally. shutterstock

December 3, 2015

What the death of two men teaches us about our blind spot in the AIDS response

Dean Peacock, University of Cape Town

Although men make up two-thirds of HIV-related deaths, there are not enough services geared towards helping them.

South Africa’s successes in HIV treatment have been marred by challenges in improving HIV prevention methods. Reuters/Nacho Doce

December 1, 2015

South Africa has excelled in treating HIV – prevention remains a disaster

Willem Daniel Francois Venter, University of the Witwatersrand; Saiqa Mullick, University of the Witwatersrand, and Sinead Delany-Moretlwe, University of the Witwatersrand

With nearly one-fifth of the globe's HIV positive population, South Africa has the largest anti-retroviral program in the world. But HIV prevention still presents a big challenge for the country.

Top contributors

Willem Daniel Francois Venter
Deputy Executive Director, Wits Reproductive Health and HIV Institute, University of the Witwatersrand
Adam Habib
Vice-Chancellor and Principal, University of the Witwatersrand
Charles Shey Wiysonge
Director, Cochrane South Africa, South African Medical Research Council
Sinead Delany-Moretlwe
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
Saiqa Mullick
Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand
Dean Peacock
Honorary Senior Lecturer, School of Public Health, University of Cape Town
Liesl Page-Shipp
Director: Health Programmes in Special Populations, Aurum Institute
Obinna Onwujekwe
Professor of Health Economics and Policy and Pharmaco-economics/pharmaco-epidemiology in the Departments of Health Administration & Management and Pharmacology and Therapeutics, College of Medicine, University of Nigeria
Linda-Gail Bekker
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Nelly Mugo
Principal investigator, Kenya Medical Research Institute
John Idoko
Professor, University of Jos
David Serwadda
Former Head of the school of Public Health, Makerere University
Chinyere Mbachu
Lecturer in the Department of Community Medicine, University of Nigeria
Bill Gates
Honorary doctorate, Addis Ababa University